thyroid cancer glp 1 GLP-1 receptor agonist use for more than year may increase risk Glucagon-like peptide-1 medicines and cancer

The newer anti-obesity medications (AOMs), like the GLP-1 medications indicated for weight loss (i.e., Wegovy and Saxenda ), appear to provide a new hope for many, although they still come with some gastrointestinal side effects

Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study

Your Personal Weight Loss Solutions Find the perfect treatment for real results

If GI symptoms are still significant at the end of a four-week block, the documented approach is to hold the current dose longer rather than escalate on schedule

If you are pregnant, breastfeeding, or planning to become pregnant, do not take Trulicity